Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LR-CD in untreated low-grade non-Hodgkin lymphoma
NCT00784927Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2008
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of lenalidomide in non-Hodgkin lymphoma (NHL), sponsored by Mayo Clinic. Started Nov 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00784927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784927.